Distinguishing Normal Cognitive Aging From Pathological Decline: A Critical Review

Distinguishing normal cognitive aging from pathological cognitive decline remains a central challenge in aging research and clinical practice, particularly in the context of rapidly aging populations worldwide. This article presents a critical narrative review that examines the conceptual, clinical, and biological boundaries separating age-associated cognitive change from disease-related decline. Drawing on evidence from neuropsychological, neurobiological, neuroimaging, and biomarker-based studies, the review synthesizes findings across traditionally siloed domains to evaluate their diagnostic utility and limitations. The literature indicates that normal cognitive aging is typically characterized by gradual, domain-specific changes with preserved functional independence, whereas pathological decline follows accelerated, progressive trajectories that disrupt multiple cognitive domains and daily functioning. While neurobiological and biomarker markers provide important mechanistic insights, their diagnostic specificity remains limited when considered in isolation, particularly in early stages. The unique contribution of this review lies in its integrative diagnostic framing, which conceptualizes cognitive aging as a multidimensional and longitudinal process requiring the convergence of cognitive performance, functional impact, biological vulnerability, and contextual modifiers. By reframing diagnostic differentiation through this integrative lens, the review highlights pathways for improving early detection, refining preventive strategies, and advancing precision medicine approaches aimed at promoting cognitive health and reducing the burden of age-related cognitive disorders.